11 Focused Summits, One Unified Mission
May 26-29, 2026
Nashville, TN
The Specialty Summit USA brings together senior executives and front-line experts across biopharma, specialty pharmacy, technology, advocacy, and care delivery to:
Engage in structured, candid dialogue grounded in real-world execution
Surface field-validated insights that inform access strategy, program design, and product planning
Align cross-functional stakeholders around real-time operational and access challenges
Identify disconnects between policy intent and on-the-ground execution before they become systemic barriers
Co-create practical solutions that accelerate patient access and support across complex specialty therapies
Participate in experience-driven, professionally moderated discussions designed to inform decision-making and guide action
Under the Specialty Summit USA umbrella, we are proud to launch an expansive conference series covering 11 therapeutic areas.
Each summit is designed to deliver specialty-specific insights while fostering cross-functional collaboration and knowledge sharing.
The 2026 Specialty Summit USA portfolio includes:
Wednesday, May 27, 2026
Thursday, May 28, 2026
Friday, May 29, 2026
Who Should Attend
This summit is built for innovators shaping the future of advanced therapies — those bringing treatments from development to delivery.
You’ll find immense value if you’re focused on:
Navigating access and reimbursement realities for high-cost, one-time therapies
Designing patient support strategies that align with payer expectations and policy shifts
Building launch frameworks that integrate affordability, sustainability, and stakeholder trust
Collaborating across providers, payers, and partners to strengthen real-world implementation
Translating innovation into impact — ensuring every approved therapy reaches the patients it was created for
If you’re ready to move beyond the science to solve the access equation, this summit is where the right conversations — and the right connections — happen.
-
Vice Presidents and Directors of Market Access
Managed Markets and Reimbursement Strategy Executives
Commercial Operations and Field Deployment Leaders
Franchise Heads and Brand Directors by Therapeutic Area
Business Development and Strategic Partnerships Leaders
-
Patient Access Services Executives
HUB Program Directors and Managers
Co-Pay and Affordability Strategy Leaders
Specialty Pharmacy Integration Managers
-
Medical Affairs Directors and Field MSL Leads
Clinical Development and Investigator Relations Teams
Scientific Communications and Evidence Generation Leaders
-
HEOR (Health Economics & Outcomes Research) Executives
RWE (Real-World Evidence) and Outcomes Analytics Directors
Payer Evidence & Value Communication Leads
-
Government Affairs and Public Policy Executives
Advocacy Relations Directors
Public-Private Partnership Development Leaders
-
Trade and Distribution Executives
Specialty Pharmacy Relations Managers
Digital Therapeutics and Telehealth Commercial Teams
-
Specialty pharmacies, HUBs, technology platforms, and access partners that work alongside pharmaceutical manufacturers to support every step of the patient journey—streamlining medication access, enhancing affordability support, and removing barriers to ensure timely, coordinated care.
-
Pharmacies that manage the distribution and support of high-cost, complex therapies—ensuring patients receive timely access, education, and coordinated care.
-
Mission-driven organizations that provide critical support services, financial assistance, education, and advocacy to reduce barriers and improve access for underserved patient populations.
-
If your organization is navigating medication access, reimbursement, or patient affordability challenges — this is the meeting for your team.
Recommended roles include:
Executive Leadership: Chief Medical Officer, Chief Pharmacy Officer, Chief Operating Officer, Chief Nursing Officer, VP of Specialty Services, or VP of Population Health
Pharmacy & Clinical Management: Pharmacy Director, Specialty Pharmacy Manager, Infusion Center Manager, Ambulatory Care Director, or Clinical Pharmacist Leader
Access & Financial Navigation Teams: Director of Patient Access, Financial Counselor Manager, Reimbursement Manager, Medication Assistance or Financial Navigation Program Lead
Practice Administration: Practice Manager, Billing and Coding Lead, Compliance Officer, Revenue Cycle Director, or Payer Relations Manager
Independent Practices & Specialty Clinics: Physicians, Nurse Practitioners, Office Managers, or Access Coordinators working directly with patients and payers
-
Payer and health plan leaders responsible for coverage, formulary, and utilization management decisions for high-cost and complex therapies. This includes medical and pharmacy directors, policy and strategy leaders, and teams shaping specialty drug management, reimbursement, and value-based care models.
Agenda Overview
At the Specialty Summit USA, you will engage in practical, real-world conversations focused on navigating medication access across complex, multi-specialty care pathways. Every session is built for execution — connecting policy, affordability, distribution, and frontline experience to drive meaningful progress in patient access.
Key Sessions include:
Registration & Networking Breakfast
Opening Remarks: Aligning on the Realities of Access Today
Opening Keynote: The State of Access in 2026 — Policy, Cost, and Patient Impact
Coverage Is Not Access: Evaluating Payer Policy Performance in Practice
Utilization Management in Execution: Where Policy Design Meets Operational Reality
The Affordability Gap: When Coverage Exists but Treatment Still Stalls
Lunch & Peer Networking
Specialty Distribution Strategy and System-Wide Impact
HUB Models at an Inflection Point: Performance, Alignment, and What Comes Next
Frontline Impact: How Access Decisions Affect Patients and Care Teams
Closing Executive Panel: The Path Forward — Aligning Policy, Operations, and Patient Impact
If you are shaping the strategy behind tomorrow’s therapies — this is where your next breakthrough conversation begins.
From the Hosts of The Specialty Summit USA
“In today’s landscape, speed, precision, and patient outcomes matter more than ever,” said Elizabeth Johnson, Co-CEO of Prescribe+. “The Specialty Summit USA delivers actionable insights that industry leaders can apply immediately to enhance access strategies and cross-functional alignment”
"We are creating an insight-rich forum where patient access challenges become solving strategies—driven by the very providers, medication access and biologics coordinators, pharmacists, and advocates who live them every day," added Melissa Paige, Co-CEO of Prescribe+.